Cargando…
RESPONSIVENESS OF THE NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE-25 TO VISUAL ACUITY GAINS IN PATIENTS WITH DIABETIC MACULAR EDEMA: Evidence From the RIDE and RISE Trials
PURPOSE: To evaluate the responsiveness of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in patients with diabetic macular edema using data from the RIDE and RISE trials. METHODS: Patients were randomized to monthly intravitreal ranibizumab 0.3 mg, 0.5 mg, or sham injectio...
Autores principales: | Suñer, Ivan J., Bressler, Neil M., Varma, Rohit, Dolan, Chantal M., Ward, James, Turpcu, Adam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Retina
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470864/ https://www.ncbi.nlm.nih.gov/pubmed/27668928 http://dx.doi.org/10.1097/IAE.0000000000001316 |
Ejemplares similares
-
Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trials
por: Dugel, Pravin U, et al.
Publicado: (2016) -
Relevance of Visual Acuity Measurement for Therapeutic Decisions in Diabetic Macular Edema
por: Mathis, Thibaud, et al.
Publicado: (2023) -
Effect of macular photocoagulation on visual acuity of Omani patients with clinically significant macular edema
por: Zaidi, Zafar A., et al.
Publicado: (2009) -
Quantitative effect of subretinal fluid and intraretinal edema on visual acuity in uveitic cystoid macular edema
por: Weldy, Eric W., et al.
Publicado: (2021) -
Diabetic Population-Based Model to Estimate Impact of Ranibizumab on Diabetic Retinopathy Severity in Patients with Diabetic Macular Edema
por: Varma, Rohit, et al.
Publicado: (2020)